Apotheek Sint-Dimpna SRL
1.0 FTEApotheek Sint-Dimpna reported total assets of 539,460 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026), with 1 full-time equivalent.
The score of Apotheek Sint-Dimpna shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Sint-Dimpna's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
Apotheek Sint-Dimpna's financial analysis
- Solvency20.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Sint-Dimpna
Apotheek Sint-Dimpna's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1005.778.152
- VAT number
- BE1005778152
- Peppol
- Registered · 0208:1005778152 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Feb 2024
- Registered office
- 2440 Geel
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Sint-Dimpna (SRL) has been based in Geel since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 91,317 € and equity of 110,346 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 20.5%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Sint-Dimpna
Companies in the same business, of comparable size and area, outside its group.
- Arklin Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 577,623 €
- Lidefarma Retail sale of pharmaceutical products Lierde · balance sheet 495,027 €
- Talpa Farma Retail sale of pharmaceutical products Anderlecht · balance sheet 547,932 €
- Kesters Pharma Invest Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet 469,134 €
- Apone Retail sale of pharmaceutical products Hemiksem · balance sheet 653,679 €
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Pharmalis Retail sale of pharmaceutical products Neufchâteau · balance sheet €1.10m
- Lotte Scheldeman Retail sale of pharmaceutical products Bornem · balance sheet 742,475 €
Frequently asked questions about Apotheek Sint-Dimpna
What is the revenue of Apotheek Sint-Dimpna?
Apotheek Sint-Dimpna files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Sint-Dimpna?
In Belgium, the VAT number is the company number prefixed with BE: BE1005778152 for Apotheek Sint-Dimpna, if the company is VAT-registered. Its company number (CBE) is 1005.778.152.
Where is the registered office of Apotheek Sint-Dimpna?
According to the CBE register, the registered office of Apotheek Sint-Dimpna is in 2440 Geel.
What is the equity of Apotheek Sint-Dimpna?
At the close of the 2025 financial year, the equity of Apotheek Sint-Dimpna amounts to 110,346 €, a solvency of 20.5% of total assets.
How many people work at Apotheek Sint-Dimpna?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Sint-Dimpna?
The register lists 2 active mandates at Apotheek Sint-Dimpna. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Sint-Dimpna
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →